2025-01-16 21:18:47
CStone announces China's NMPA has accepted its new drug application for sugemalimab in the treatment of stage III NSCLC
Corporate/ 2023-07-23
CStone announces China's NMPA has a...

Sugemalimab becomes the world\'s first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patie...

Thrombosis Research Institute (TRI) Shares Six New GARFIELD-AF And RIVER Real-world Data Analyses At ESC Congress 2021
Health/ 2023-07-22
Thrombosis Research Institute (TRI) Shar...

- Four GARFIELD-AF e-posters shine light on managing atrial fibrillation (AF) in patients with clinically challenging conditions and diabete...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release